Asymmetric membrane capsules for delivery of poorly water-soluble drugs by osmotic effects

被引:38
作者
Wang, CY
Ho, HO
Lin, LH
Lin, YK
Sheu, MT
机构
[1] Taipei Med Univ, Grad Inst Pharmaceut Sci, Taipei 11031, Taiwan
[2] Shin Kong Wu Ho Su Mem Hosp, Dept Pharm, Taipei, Taiwan
[3] Taipei Med Univ Hosp, Dept Dent, Taipei, Taiwan
关键词
asymmetrical membrane; osmotic effect; poorly water-soluble drugs; sodium lauryl sulfate;
D O I
10.1016/j.ijpharm.2005.03.026
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A non-disintegrating polymeric capsule system, in which asymmetric membrane offers an improved osmotic effect, was used to deliver poorly water-soluble drugs in a control manner. The capsule wall membrane was made by a phase inversion process, in which asymmetric membrane was formed on stainless-steel mold pins by dipping the mold pins into a coating solution containing a polymeric material followed by dipping into a quench solution. This study evaluates the influence of coating formulation that was cellulose acetate (CA), ethylcellulose (EC), and plasticizer (glycerin and triethyl citrate). Results show capsule that made by CA with glycerin (formulation A), which appear in asymmetric structure and are able to release chlorpheniramine maleate (CM) in significant percentage. Two poorly water-soluble drugs of felodipine (FL) and nifedipine (NF) were selected as the model drug to demonstrate how the controlled release characteristics can be manipulated by the design of polymeric capsules with an asymmetric membrane and core formulations. Results show that sodium lauryl sulfate (SLS) is able to promote the release of FL from polymeric capsules prepared with CA with asymmetrical membrane. The addition of solubilizer, including RH40, PVP K-17, and PEG 4000 could enhance the release of FL but with an extent not being related to its solubility. Based on these results, influence of core formulation variables, including the viscosity and added amount of hydroxypropyl methylcellulose (HPMC), the added amount of SLS, and drug loading were examined on the release of NF. It was found that HPMC of 50 cps was suitable to be a thickening agent and both added amount of HPMC and SLS showed a comparable and profoundly positive effect, whereas NF loading had no influence on the drug release percent and rate. There existed a synergistic interaction between HPMC and SLS on the release percent and rate. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:89 / 97
页数:9
相关论文
共 9 条
[1]   ASYMMETRIC-MEMBRANE TABLET COATINGS FOR OSMOTIC DRUG-DELIVERY [J].
HERBIG, SM ;
CARDINAL, JR ;
KORSMEYER, RW ;
SMITH, KL .
JOURNAL OF CONTROLLED RELEASE, 1995, 35 (2-3) :127-136
[2]   Investigations on the drug releasing mechanism from an asymmetric membrane-coated capsule with an in situ formed delivery orifice [J].
Lin, YK ;
Ho, HO .
JOURNAL OF CONTROLLED RELEASE, 2003, 89 (01) :57-69
[3]   OSMOTIC DRUG-DELIVERY - A REVIEW OF THE PATENT LITERATURE [J].
SANTUS, G ;
BAKER, RW .
JOURNAL OF CONTROLLED RELEASE, 1995, 35 (01) :1-21
[4]  
Swanson D R, 1987, Am J Med, V83, P3, DOI 10.1016/0002-9343(87)90629-2
[5]   ELEMENTARY OSMOTIC PUMP [J].
THEEUWES, F .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1975, 64 (12) :1987-1991
[6]  
THEEUWES F, 1978, Patent No. 4088864
[7]   Asymmetric membrane capsules for osmotic drug delivery - II. In vitro and in vivo drug release performance [J].
Thombre, AG ;
Cardinal, JR ;
DeNoto, AR ;
Gibbes, DC .
JOURNAL OF CONTROLLED RELEASE, 1999, 57 (01) :65-73
[8]   Asymmetric membrane capsules for osmotic drug delivery - I. Development of a manufacturing process [J].
Thombre, AG ;
Cardinal, JR ;
DeNoto, AR ;
Herbig, SM ;
Smith, KL .
JOURNAL OF CONTROLLED RELEASE, 1999, 57 (01) :55-64
[9]   Delivery of glipizide from asymmetric membrane capsules using encapsulated excipients [J].
Thombre, AG ;
DeNoto, AR ;
Gibbes, DC .
JOURNAL OF CONTROLLED RELEASE, 1999, 60 (2-3) :333-341